US4739046A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Soluble phosphorylated glucan
Assignee: DILUZIO DANIEL V
•
Filing: 1985-08-19
•
Granted: 1988-04-19
•
Expires: 2005-08-19
Abstract
Abstract A new class of soluble phosphorylated glucans is described as well as the process for making the same. According to a preferred embodiment, the soluble phosphorylated glucan is derived from the yeast Saccharomyces cerevisiae. The soluble phosphorylated glucans are useful for prophylactic and therapeutic applications against neoplastic, bacteria, viral, fungal and parasitic diseases. Additionally, they may be administered as a non-toxic adjuvant, in combination with chemotherapy. The soluble phosphorylated glucans are also useful for stimulating macrophage cells, either in vivo or in vitro, to produce a cytotoxic/cyctostatic factor effective against cancer cells.
Inventors
- 👤 Nicholas R. Di Luzio
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-06 16:14
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70; A61K31/715; C; C08; C08B; C08B37/00; C08B37/0006; C08B37/0024; A61P; A61P31/00; A61P31/04; A61P35/00; A61P37/00; C07; C07H; C07H3/00; C07H3/06; C12; C12P; C12P19/00; C12P19/04
Claims Analysis
Total Claims: 32
Claim 1
Independent Claim
51 words
A soluble glucan, comprising a phosphorylated poly-[β-(1-3)glucopyranose] chain which is characterized by: (a) the capability of dissolving in water or an aqueous solution; (b) being non-toxic, non-immunogenic and substantially non-pyrogenic; and (c) the capability of exerting a pronouced immunobiological response when administered in vivo to an animal or to a human.
Claim 2
Dependent Claim
51 words
A soluble glucan, comprising a phosphorylated poly-[β-(1-3)glucopyranose] chain which is characterized by: (a) the capability of dissolving in water or an aqueous solution; (b) being non-toxic, non-immunogenic and substantially non-pyrogenic; and (c) the capability of exerting a pronouced immunobiological response when administered in vivo to an animal or to a human.
Claim 3
Dependent Claim
25 words
The soluble glucan according to claim 1, further characterized by the substantially complete absence of triple helical chains as determined by nuclear magnetic resonance spectroscopy.
Claim 4
Dependent Claim
22 words
The soluble glucan according to claim 1, further characterized by having a degree of phosphorylation ranging from about 1.4% to about 3.4%.
Claim 5
Dependent Claim
22 words
The soluble glucan according to claim 1, further chracterized by having a molecular weight ranging from about 10,000 to about 100,000 daltons.
Claim 6
Dependent Claim
22 words
The soluble glucan according to claim 1, further characterized by having a molecular weight ranging from about 100,000 to about 500,000 daltons.
Claim 7
Dependent Claim
14 words
The soluble glucan according to claim 1, which is obtained from a microbial source.
Claim 8
Dependent Claim
15 words
The soluble glucan according to claim 6, in which the microbial source comprises Saccahromyces cerevisiae.
Claim 9
Dependent Claim
15 words
The soluble glucan according to claim 6, in which the microbial source comprises Coriolus versicolor.
Claim 10
Dependent Claim
54 words
A composition, comprising a phosphorylated poly-[β-(1-3)glucopyranose] chain which is characterized by: (a) the capability of dissolving in water or an aqueous solution; (b) being non-toxic, non-immunogenic and substantially non-pyrogenic; and (c) the capability of exerting a pronouced immunobiological resonse when administered in vivo to an animal or to a human in an aqueous solution.
Claim 11
Dependent Claim
54 words
A composition, comprising a phosphorylated poly-[β-(1-3)glucopyranose] chain which is characterized by: (a) the capability of dissolving in water or an aqueous solution; (b) being non-toxic, non-immunogenic and substantially non-pyrogenic; and (c) the capability of exerting a pronouced immunobiological resonse when administered in vivo to an animal or to a human in an aqueous solution.
Claim 12
Dependent Claim
31 words
The composition according to claim 9, in which the poly-[β-(1-3) glucopyranose] chain is further characterized by the substantially complete absence of triple helical chains as determined by nuclear magnetic resonance spectroscopy.
Claim 13
Dependent Claim
28 words
The composition according to claim 9, in which the poly-[β-(1-3) glucopyranose] chain is further characterized by having a degree of phosphorylation ranging from about 1.4% to about 3.4%.
Claim 14
Dependent Claim
28 words
The composition according to claim 9, in which the poly-[β-(1-3) glucopyranose] chain is further chracterized by having a molecular weight ranging from about 10,000 to about 100,000 daltons.
Claim 15
Dependent Claim
28 words
The composition according to claim 9, in which the poly-[β-(1-3) glucopyranose] chain is further characterized by having a molecular weight ranging from about 100,000 to about 500,000 daltons.
Claim 16
Dependent Claim
13 words
The composition according to claim 9, which is obtained from a microbial source.
Claim 17
Dependent Claim
14 words
The composition according to claim 14, in which the microbial source comprises Saccharomyces cerevisiae.
Claim 18
Dependent Claim
14 words
The composition according to claim 14, in which the microbial source comprises Coriolus versicolor.
Claim 19
Independent Claim
76 words
A method for preparing a non-toxic, non-immunogenic, substantially non-pyrogenic soluble phosphorylated glucan capable of exerting a profound immunbiological response when administered in vivo in animals or humans, comprising: (a) dissolving a particulate glucan or a glucan protein complex in a highly polar solvent which contains a strong chaotropic agent; (b) reacting the resultant dissolved glucan with phosphoric acid to form a soluble phosphorylated glucan; and (c) recovering the resultant soluble phosphorylated glucan from the reaction mixture.
Claim 20
Independent Claim
76 words
A method for preparing a non-toxic, non-immunogenic, substantially non-pyrogenic soluble phosphorylated glucan capable of exerting a profound immunbiological response when administered in vivo in animals or humans, comprising: (a) dissolving a particulate glucan or a glucan protein complex in a highly polar solvent which contains a strong chaotropic agent; (b) reacting the resultant dissolved glucan with phosphoric acid to form a soluble phosphorylated glucan; and (c) recovering the resultant soluble phosphorylated glucan from the reaction mixture.
Claim 21
Dependent Claim
14 words
The method according to claim 17, in which the highly polar solvent comprises dimethylsulfoxide.
Claim 22
Dependent Claim
14 words
The method according to claim 17, in which the strong chaotropic agent comprises urea.
Claim 23
Dependent Claim
78 words
The method according to claim 17, in which the particulate glucan or glucan protein complex is dissolved by a method comprising the sequential steps of: (a) suspending a particulate glucan or a glucan protein complex in a highly polar solvent which contains a strong chaotropic agent to form a mixture; (b) heating the mixture to about 50°-150° C.; (c) adding phosphoric acid to the mixture; (d) allowing the mixture to react for about 1-12 hours at 50°-150° C.
Claim 24
Dependent Claim
16 words
The method according to claim 20, in which the mixture is heated to about 100° C.
Claim 25
Dependent Claim
16 words
The method according to claim 20, in which the mixture comprises about 4-12M urea in dimethylsulfoxide.
Claim 26
Dependent Claim
31 words
The method according to claim 17, in which the glucan is reacted with phosphoric acid for a sufficient period so that phosphorylation of the resultant soluble phosphorylate glucan is substantially complete.
Claim 27
Dependent Claim
50 words
The method according to claim 17, in which the soluble phosphorylated glucan is recovered by: (a) allowing the soluble phosphorylated glucan to precipitate; (b) adding a sufficient amount of water to resuspend the precipitated soluble phosphorylated glucan; and (c) removing all components of less than about 10,000 daltons molecular weight.
Claim 28
Dependent Claim
16 words
The method according to claim 17, in which the particulate glucan is obtained from Saccharomyces cerevisiae.
Claim 29
Dependent Claim
17 words
The method according to claim 17, in which the glucan protein complex is obtained from Coriolus versicolor.
Claim 30
Dependent Claim
133 words
The method according to claim 17, in which the particulate glucan is obtained by a method comprising the steps of: (a) suspending an aliquot of fungal cells in an aqueous solution of hydroxide to form a mixture; (b) heating the mixture to about 50°-150° C.; (c) removing the supernatant from resulting residue; (d) suspending the residue in the aqueous solution of hydroxide; (e) repeating steps b and c, two or three times; (f) adding hydrochloric acid to the residue to of step e form an acidic mixture; (g) heating the acidic mixture to about (h) removing the supernatant; (i) repeating steps f and g, two times; (j) washing the residue with water; (k) repeatedly extracting the residue with ethanol until the supernatant is essentially colorless; and (l) isolating the non-soluble polyglucose composition formed.
Claim 31
Dependent Claim
32 words
A method for stimulating macrophage cells in vivo to produce and secrete a soluble cytotoxic/cytostatic factor, comprising: administering to an animal or a human the soluble phosphorylated glucan according to claim 1.
Claim 32
Dependent Claim
9 words
The soluble cytotoxic/cytostatic factor produced according to claim 28.
References Cited (Backward Citations)
US3081226A
Cited
US3396082A
Cited
US4493894A
Cited
US4138479A
Cited
US4202966A
Cited
US4225673A
Cited
US4237266A
Cited
US4396611A
Cited
US4340673A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1991-04-19 | 1991-10-19 | 1992-04-19 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1995-04-19 | 1995-10-19 | 1996-04-19 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1999-04-19 | 1999-10-19 | 2000-04-19 | $7700.00 | Window Closed / Lapsed |